Alnylam Pharmaceuticals (ALNY) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Alnylam Pharmaceuticals (ALNY) over the last 14 years, with Q3 2025 value amounting to -$191.4 million.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments rose 255.49% to -$191.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$191.4 million, marking a year-over-year increase of 255.49%. This contributed to the annual value of $562.0 million for FY2024, which is 639.47% up from last year.
- According to the latest figures from Q3 2025, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments is -$191.4 million, which was up 255.49% from -$192.4 million recorded in Q2 2025.
- Over the past 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments peaked at $562.0 million during Q4 2024, and registered a low of -$238.1 million during Q2 2021.
- Over the past 5 years, Alnylam Pharmaceuticals' median Other Gross PP&E Adjustments value was -$198.3 million (recorded in 2024), while the average stood at -$65.1 million.
- Within the past 5 years, the most significant YoY rise in Alnylam Pharmaceuticals' Other Gross PP&E Adjustments was 2418.66% (2021), while the steepest drop was 720.04% (2021).
- Over the past 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $392.9 million in 2021, then increased by 17.57% to $462.0 million in 2022, then grew by 14.35% to $528.2 million in 2023, then increased by 6.39% to $562.0 million in 2024, then crashed by 134.05% to -$191.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$191.4 million for Q3 2025, versus -$192.4 million for Q2 2025 and -$197.2 million for Q1 2025.